140 related articles for article (PubMed ID: 35497882)
41. Identification of circulating microRNAs as potential biomarkers for detecting acute ischemic stroke.
Li P; Teng F; Gao F; Zhang M; Wu J; Zhang C
Cell Mol Neurobiol; 2015 Apr; 35(3):433-447. PubMed ID: 25410304
[TBL] [Abstract][Full Text] [Related]
42. Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.
Yan L; Jiao D; Hu H; Wang J; Tang X; Chen J; Chen Q
Exp Biol Med (Maywood); 2017 Apr; 242(7):709-717. PubMed ID: 28299977
[TBL] [Abstract][Full Text] [Related]
43. Analysis of microRNA expression profiles in human bronchial epithelial cells infected by Chlamydia psittaci.
Liu L; Chen X; Tang T; Chen L; Huang Q; Li Z; Bai Q; Chen L
Microb Pathog; 2021 May; 154():104837. PubMed ID: 33689813
[TBL] [Abstract][Full Text] [Related]
44. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
45. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
46. miRNA Genetic Variants Alter Their Secondary Structure and Expression in Patients With RASopathies Syndromes.
de Carvalho JB; de Morais GL; Vieira TCDS; Rabelo NC; Llerena JC; Gonzalez SMC; de Vasconcelos ATR
Front Genet; 2019; 10():1144. PubMed ID: 31798637
[TBL] [Abstract][Full Text] [Related]
47. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
48. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
[TBL] [Abstract][Full Text] [Related]
49. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
[TBL] [Abstract][Full Text] [Related]
50. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
Li C; Feng S; Chen L
Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
[TBL] [Abstract][Full Text] [Related]
51. Identification of Hub Genes Associated with Hypertension and Their Interaction with miRNA Based on Weighted Gene Coexpression Network Analysis (WGCNA) Analysis.
Li Z; Chyr J; Jia Z; Wang L; Hu X; Wu X; Song C
Med Sci Monit; 2020 Sep; 26():e923514. PubMed ID: 32888289
[TBL] [Abstract][Full Text] [Related]
52. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
[TBL] [Abstract][Full Text] [Related]
53. The diagnostic values of circulating miRNAs for hypertension and bioinformatics analysis.
Zhang X; Wang X; Wu J; Peng J; Deng X; Shen Y; Yang C; Yuan J; Zou Y
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29961674
[TBL] [Abstract][Full Text] [Related]
54. A Pilot Study Identifying a Set of microRNAs As Precise Diagnostic Biomarkers of Acute Kidney Injury.
Aguado-Fraile E; Ramos E; Conde E; Rodríguez M; Martín-Gómez L; Lietor A; Candela Á; Ponte B; Liaño F; García-Bermejo ML
PLoS One; 2015; 10(6):e0127175. PubMed ID: 26079930
[TBL] [Abstract][Full Text] [Related]
55. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
Li C; Hu X; Li L; Li JH
J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
[TBL] [Abstract][Full Text] [Related]
56. Identification of biomarkers and construction of a microRNA-mRNA regulatory network for ependymoma using integrated bioinformatics analysis.
Yang B; Dai JX; Pan YB; Ma YB; Chu SH
Oncol Lett; 2019 Dec; 18(6):6079-6089. PubMed ID: 31788082
[TBL] [Abstract][Full Text] [Related]
57. Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients.
Roth P; Keller A; Hoheisel JD; Codo P; Bauer AS; Backes C; Leidinger P; Meese E; Thiel E; Korfel A; Weller M
Eur J Cancer; 2015 Feb; 51(3):382-90. PubMed ID: 25534293
[TBL] [Abstract][Full Text] [Related]
58. Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma.
Su L; Zhang J; Zhang X; Zheng L; Zhu Z
Med Oncol; 2021 Oct; 38(12):141. PubMed ID: 34655361
[TBL] [Abstract][Full Text] [Related]
59. Differential miRNAs profile and bioinformatics analyses in bone marrow mesenchymal stem cells from adolescent idiopathic scoliosis patients.
Hui S; Yang Y; Li J; Li N; Xu P; Li H; Zhang Y; Wang S; Lin G; Li S; Qiu G; Zhao RC; Zhang J; Zhuang Q
Spine J; 2019 Sep; 19(9):1584-1596. PubMed ID: 31100472
[TBL] [Abstract][Full Text] [Related]
60. Intrarenal microRNA signature related to the fibrosis process in chronic kidney disease: identification and functional validation of key miRNAs.
Yu J; Yu C; Feng B; Zhan X; Luo N; Yu X; Zhou Q
BMC Nephrol; 2019 Aug; 20(1):336. PubMed ID: 31455266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]